Study guide

8.3 Helicobacter pylori Detection and GI Pathogenicity

ASCP Microbiology Technologist M ASCP

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current M(ASCP) Exam Facts 1.2 CAT, Scoring, Retakes, and CMP 1.3 Eligibility Routes and Clinical Experience

2 Preanalytic: Collection and Transport

2.1 Patient Identification and Specimen Labeling 2.2 Specimen Collection, Sterile Technique, and Blood Cultures 2.3 Transport Devices, Atmosphere, Time, and Temperature

3 Preanalytic: Processing, Media, and Incubation

3.1 Prioritization, Rejection, and Specimen Preparation 3.2 Media Types, Components, and Selection 3.3 Inoculation, Incubation Conditions, and Slide Preparation

4 Preanalytic: Stains

4.1 Gram Stain: Procedure, Principle, and Interpretation 4.2 Acid-Fast and Modified Acid-Fast Stains 4.3 KOH, Calcofluor-White, Trichrome, Giemsa, and Acridine Orange

5 Bacteriology: Blood and Bone Marrow

5.1 Blood Culture Systems and Rapid Identification 5.2 Bloodstream Pathogens and Skin Flora Significance 5.3 Endocarditis, Bone Marrow Pathogens, and Pathogenicity

6 Bacteriology: CSF and Sterile Body Fluids

6.1 CSF Sources and Acute Meningitis Pathogens 6.2 Shunt Infections, CSF Correlates, Antigen and Molecular Methods 6.3 Sterile Body Fluids: Pathogens, Flora, and Molecular Methods

7 Bacteriology: Respiratory Tract

7.1 Lower Respiratory Specimens, CAP, and HAP Pathogens 7.2 Cystic Fibrosis Pathogens and Quantitative Reporting 7.3 Upper Respiratory: Pharyngitis, Otitis, Sinusitis, Antigen/Molecular

8 Bacteriology: Gastrointestinal Tract

8.1 Enteric Pathogens: Culture and Colony Morphology 8.2 Clostridioides difficile, Shiga Toxin, and Serotyping 8.3 Helicobacter pylori Detection and GI Pathogenicity

9 Bacteriology: Skin, Soft Tissue, and Bone

9.1 Skin, Soft Tissue, and Bone Pathogens 9.2 Bite Wounds and Zoonotic Infections 9.3 SST Pathogenicity and Virulence Mechanisms

10 Bacteriology: Genital Tract and Urine

10.1 Genital Flora and Vaginitis Pathogens 10.2 Neisseria gonorrhoeae, Chlamydia trachomatis, GBS, and Mycoplasma 10.3 Urinary Pathogens, Colony Counts, and Urinalysis Correlation

11 Bacteriology: Identification Methods

11.1 Colony Morphology and Rapid Presumptive Tests 11.2 Conventional Biochemicals and Commercial Kits 11.3 Automated Methods, MALDI-TOF MS, Molecular, and 16S Sequencing

12 Bacteriology: Antimicrobial Susceptibility and Resistance

12.1 Microbroth Dilution, Disk Diffusion, and Gradient Diffusion 12.2 Phenotypic Detection of Resistance 12.3 Antibiotic Classes, Intrinsic Resistance, and Genetic Markers

13 Bacteriology: Resistance Screening and Select Agents

13.1 MRSA/MSSA, VRE, ESBL/CRE Screening 13.2 BSL-3 Pathogens and Select-Agent Presumptive Identification 13.3 Laboratory Response Network and Select-Agent Pathogenicity

14 Mycobacteriology and Nocardia

14.1 Specimens, Major Pathogens, and Disease States 14.2 Acid-Fast Reaction, Colony Morphology, and Growth Characteristics 14.3 Identification Methods, Direct Molecular Detection, and TB Therapy

15 Virology

15.1 Respiratory, Vesicle, Meningitis, and GI Viruses 15.2 Hepatitis, HIV, and Immunocompromised-Host Viruses 15.3 Direct Detection Methods and HPV Cervical Screening

16 Parasitology

16.1 Blood, Tissue, and Brain Protozoa 16.2 Intestinal/Urogenital Protozoa and Helminths 16.3 Microscopy, Antigen/Molecular Detection, Insects and Arthropods

17 Mycology

17.1 Yeasts: Candida, Cryptococcus, and Malassezia 17.2 Dimorphic Fungi and Dermatophytes 17.3 Mucorales, Hyaline Molds, Pneumocystis, and Identification Methods

18 Serology

18.1 Immunoglobulin Response and Antigen-Antibody Methods 18.2 Viral Serodiagnosis: Hepatitis, EBV, HIV, CMV, Rubella, Measles 18.3 Treponema, Borrelia, and TB Infection Serodiagnosis

19 Laboratory Operations: Postanalytic Procedures and Quality

19.1 Documentation, Critical Values, Corrected Reports, and Public Health 19.2 Quality Control, Root-Cause Analysis, and POCT 19.3 Proficiency Testing, Competency, and Accreditation

20 Laboratory Operations: Safety, Mathematics, and Instrumentation

20.1 Biosafety, PPE, Bloodborne Pathogens, and SDS 20.2 Emergencies and Packaging/Transportation of Specimens 20.3 Laboratory Mathematics and Instrumentation

8.3 Helicobacter pylori Detection and GI Pathogenicity

Key Takeaways Explain This Topic AI

Active H. pylori infection is supported by urea breath test, stool antigen, biopsy rapid urease (CLO), histology, or culture; IgG serology shows exposure only and does not prove active infection or eradication.

H. pylori culture is microaerophilic at 35 °C on enriched media and is not a routine stool-plate method; do not incubate it at 42 °C like Campylobacter jejuni.

Invasive enteric disease (Shigella, Salmonella T3SS, Campylobacter, Yersinia, EIEC) typically yields fecal leukocytes; toxin-mediated watery diarrhea (cholera toxin, ETEC, often C. difficile) may not.

Match virulence to organism: Shiga toxin in STEC, cholera toxin in V. cholerae, TcdA/TcdB in C. difficile, and Salmonella SPI-1/SPI-2 type III secretion for invasion.

Multiplex GI PCR is faster than culture but still needs an isolate for serotyping and public health, and a PCR-positive C. difficile result on formed stool is colonization, not disease.

Last updated: August 2026

8.3 Helicobacter pylori Detection and GI Pathogenicity

Quick Answer: Prove active H. pylori with urea breath test, stool antigen, biopsy urease, histology, or culture—not with IgG serology. Culture, when done, is microaerophilic at 35 °C and is not routine. Then map enteric disease to invasion versus toxin (Shiga, cholera toxin, C. difficile TcdA/TcdB, Salmonella T3SS) and correlate fecal leukocytes with multiplex GI PCR.

Outline II.F ends with detection methods for Helicobacter pylori and organism pathogenicity (etiology, transmission, virulence). H. pylori is not a Cary-Blair stool-culture organism. It lives in gastric mucus, not in the colon, and the laboratory question is active infection versus past exposure . The same section then asks you to explain why Shigella makes dysentery and V. cholerae makes rice-water stool, and why a multiplex PCR panel does not replace that thinking.

Helicobacter pylori: tests that prove now versus tests that prove ever

H. pylori is a curved Gram-negative rod, oxidase-positive, catalase-positive, and powerfully urease-positive . Urease hydrolyzes urea to ammonia and CO2, raising local pH so the organism survives gastric acid. That biochemistry is the principle of the urea breath test and the rapid urease (CLO) test .

  • Method Specimen Proves active infection? Exam use
  • Urea breath test Exhaled CO2 after labeled urea Yes Noninvasive diagnosis and test of eradication
  • Stool antigen EIA Feces Yes Diagnosis and test of eradication
  • Rapid urease / CLO Gastric biopsy in urea indicator Yes Endoscopy; color change from ammonia
  • Histology (Giemsa, Warthin–Starry, IHC) Gastric biopsy Yes Organisms plus gastritis on the same slide
  • Culture Gastric biopsy, microaerophilic 35 °C Yes Not routine; used for susceptibility
  • IgG serology Serum No Exposure only; not test of cure

Urea breath test. The patient drinks 13C- or 14C-labeled urea. If gastric H. pylori urease is present, labeled CO2 appears in breath. False negatives follow proton-pump inhibitors , antibiotics, and bismuth; stop PPI for about two weeks and antibiotics/bismuth for four weeks when the question is eradication. This is an active-infection test.

Stool antigen. Immunoassay for H. pylori antigen in feces also indicates current gastric infection and is the usual noninvasive test of eradication (often ≥4 weeks after therapy). It is not a stool culture and it does not mean the organism is an enteric diarrheal pathogen.

Serology does not prove active infection. IgG can remain positive for years after the organism is gone. Do not use serology to confirm eradication, to test children as a first-line active-disease test, or to explain current ulcer symptoms after treatment. A positive IgG means the patient met H. pylori at some time, not that organisms are in the stomach today.

Biopsy rapid urease (CLO or equivalent). A gastric antral biopsy is placed in a urea-containing well with a pH indicator. Urease-positive organisms turn the well alkaline (yellow to pink/red). Sensitivity falls if the patient is on PPI or if the biopsy misses the colonized patch; histology backs it up.

Histology shows curved organisms in mucus on Giemsa, silver (Warthin–Starry), or immunohistochemistry, plus gastritis. It is still the gold-standard tissue test in many endoscopy suites.

Culture is not routine. When ordered (usually for refractory infection and susceptibility), inoculate enriched chocolate or selective Helicobacter media from a gastric biopsy, incubate microaerophilic at 35 °C (not 42 °C), and hold up to 5–7 days. H. pylori is more fastidious and more temperature-sensitive than C. jejuni . Colonies are small, translucent, and oxidase/catalase/urease-positive. Stool is the wrong specimen for this culture.

Virulence that matters for gastric disease: urease for acid survival, flagella for mucus motility, VacA cytotoxin, and CagA (type IV secretion) associated with peptic ulcer, gastric adenocarcinoma, and MALT lymphoma. Transmission is person-to-person, often fecal–oral or oral–oral in childhood—not undercooked poultry.

Exam scenario. Dyspepsia, positive IgG, negative stool antigen: serology is leftover antibody, not active infection—do not treat on IgG alone. Second scenario: a bench incubates a gastric biopsy at 42 °C on Campy-BAP “because it is a campylobacter.” That plate is the wrong temperature and usually the wrong medium for H. pylori .

Loading diagram... H. pylori active-infection tests versus enteric invasion and toxin

Evidence of active H. pylori infection by test class

Pathogenicity: etiology, transmission, invasion versus toxin

Think in three layers the outline names: who gets sick and from where , how the organism gets in , and whether it invades mucosa or intoxicates from the lumen .

Fecal–oral, food, water, zoonoses. Shigella has a tiny inoculum and spreads person-to-person (day care, institutions) more than food. Salmonella is foodborne and zoonotic: poultry, eggs, produce, and reptiles. C. jejuni is poultry, unpasteurized milk, and puppies. Y. enterocolitica is pork and chitterlings. V. cholerae is fecally contaminated water; V. parahaemolyticus and V. vulnificus are seafood and seawater. Aeromonas and Plesiomonas are freshwater and seafood. STEC is ground beef, produce, and petting zoos (ruminants). C. difficile is spores in the healthcare and community environment after microbiome disruption, not a picnic-potato-salad story. H. pylori is gastric colonization, not acute food poisoning.

Invasion. Shigella enters colonic M cells, multiplies in cytoplasm, and spreads cell-to-cell— dysentery with blood, mucus, and fecal leukocytes . Salmonella uses type III secretion systems : SPI-1 injects effectors for epithelial invasion, SPI-2 for survival inside macrophages; gastroenteritis is ileocolitis, and typhoidal strains disseminate. C. jejuni invades ileum and colon and is linked to Guillain–Barré via molecular mimicry of GM1 ganglioside, a pathogenicity extra the exam may attach to Campylobacter, not to STEC. Y. enterocolitica invades Peyer’s patches (invasin, Yops via T3SS) and causes mesenteric adenitis. Enteroinvasive E. coli behaves like Shigella . Invasive disease is the setting in which a fecal leukocyte, lactoferrin, or calprotectin result is often positive.

Toxin. STEC Shiga toxins (Stx1/Stx2) inhibit protein synthesis on endothelial cells and drive hemorrhagic colitis and HUS—invasion is limited; leukocytes may be fewer than in shigellosis, but blood is common. V. cholerae cholera toxin ADP-ribosylates Gs, locks adenylate cyclase on, and dumps chloride into the lumen: voluminous watery stool without fecal leukocytes. ETEC heat-labile toxin is cholera-toxin-like; heat-stable toxin raises cGMP. C. difficile TcdA and TcdB glucosylate Rho GTPases, kill colonocytes, and produce colitis that can be leukocyte-rich and even pseudomembranous; binary toxin appears in epidemic NAP1/027 strains. Salmonella is not a cholera-toxin disease on this exam; if the stem says T3SS, think invasion.

  • Organism Transmission cue Dominant virulence Fecal leukocytes
  • Shigella Person-to-person, low inoculum Invasion, some Stx in S. dysenteriae 1 Usually present
  • Salmonella (nontyphoidal) Food, reptiles T3SS (SPI-1/SPI-2) invasion Often present
  • STEC Ground beef, produce, cattle Shiga toxin Variable; blood more than classic dysentery
  • V. cholerae Water Cholera toxin Usually absent
  • C. difficile Spores, antibiotics TcdA/TcdB Often present in colitis
  • C. jejuni Poultry, raw milk Invasion, toxin/GBS mimicry Often present
  • H. pylori Person-to-person in childhood Urease, CagA, VacA Not a colon-leukocyte test
  • Correlate fecal leukocytes and multiplex GI PCR

A methylene-blue wet mount or a lactoferrin immunoassay is a rapid invasion clue, not an organism name. Leukocytes plus blood point to Shigella , Salmonella , Campylobacter , Yersinia , EIEC, or C. difficile colitis. Watery, leukocyte-poor stool points to cholera, ETEC, or viral disease—and still needs STEC toxin testing when bloody or when HUS is in the room, because STEC is toxin-mediated.

Multiplex GI PCR panels detect many of the outline organisms in hours, including Salmonella , Shigella /EIEC, Campylobacter , Yersinia , Vibrio , STEC stx , and C. difficile toxin genes. Use them. Then remember their limits: they do not serotype, they do not yield an isolate for public health, they can stay positive after recovery, and C. difficile NAAT on formed stool is colonization . A panel positive for Salmonella still goes to HE/XLD so O and H typing can happen. A panel positive for STEC still needs SMAC plus toxin confirmation and referral. Correlate the PCR with stool consistency , fecal leukocytes , and epidemiology (oysters, travel, day care, antibiotics) or you will treat colonization and miss the virulence story the outline is actually testing.

Exam scenario. Watery diarrhea after oysters, no fecal leukocytes, green TCBS colonies: toxin-mediated V. parahaemolyticus or related Vibrio , not Shigella . Fever, tenesmus, leukocytes, green HE colonies: invasive Shigella —serogroup A–D and report it. Gastric ulcer, positive urea breath test, negative IgG is possible early, but the reverse (IgG-positive, antigen-negative) is treated past infection. Work ASCP M practice questions until active-versus-serology H. pylori and invasion-versus-toxin pairings are instant.